Company: REVB
Filing Date: 2025-05-28
Form Type: 8-K
Source: 0000950170-25-078340
Chunk: 0

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-28
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

On May 23, 2025, the Company issued a press release announcing the resignation of Dr. Tidmarsh as a director of the Company. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 8.01 and in Exhibit 99.1 will not be treated as “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section. This information will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or into another filing under the Exchange Act, unless that filing expressly incorporates this information by reference.

Item 9.01 Financial Statements and Exhibits.